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Supramolecular glyco-poly-cyclodextrin functionalized thin-layer 
manganese dioxide for targeted stimulus-responsive bioimaging 
Huan Wang,a Ying Liu,a Chao Xu,a Xi Wang, a Guo-Rong Chen,a Tony D James,c Yi Zang,b* Jia Li,b* 
Xiang Maa* and Xiao-Peng Hea*
We have developed a supramoleuclar imaging probe based on thin-
layer manganese dioxide functionalized with a fluorescent, 
multivalent glyco-poly-cycolodextrin for the targeted, stimulus-
responsive bioimaging of cancer cells. 
This paper describes the supramolecular construction of a 
biocompatible thin-layer manganese dioxide-based probe for the 
targeted, biothiol-responsive fluorescence imaging of liver and 
triple-negative breast cancer cells. Target-specific imaging is 
crucial for improving the precision of diagnostics. Specificity can 
be achieved through the simultaneous targeting of a membrane 
receptor and the stimulus-responsive signal production upon 
interacting with an intracellular biomarker. However, the 
majority of the current small-molecular probes or polymeric 
materials for sensing the overexpression of an intracellular 
disease biomarker lack the ability to be actively internalized by 
living cells. To address this issue, recent literature has seen an 
active movement towards the introduction of a targeting agent 
such as aptamers, peptides and carbohydrates to the imaging 
material, increasing the accumulation, and thus the stimulus-
responsiveness of the probes in a target cell or tissue.1-3 
There are two key issues that need to be carefully considered 
to achieve targeted bioimaging. First, multivalent display of the 
targeting ligands on a material scaffold is crucial for significantly 
increasing the binding avidity for cell-surface receptors; this is 
particularly important for carbohydrate-based materials.4 On a 
second front, the materials used should be biocompatible in 
order to achieve real-world applications. Despite the extensive 
development of oligo- and polymeric architectures to realize 
multivalency through covalent bonding chemistries,5,6 simple 
yet effective functional imaging probes formed through the 
non-covalent supramolecular approaches remain much less 
explored. 
 
Fig. 1 (a) Structure of the poly-CD host polymers and the adamantane-modified 
glycoprobes as guest molecules. Schematic illustration of (b) The two-step 
supramolecular assembly forming the fluorogenic 2D probe and (c) use of the 2D 
probe for the targeted, stimulus-responsive cell imaging (GSH = glutathione). 
Here we show the construction of an imaging probe based on 
2D manganese dioxide (2D probe) using two supramolecular 
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approaches. Host-guest interaction between an adamantane-
grafted fluorescent glycoprobe and poly-β-cyclodextrins (poly-
CD) with different CD-grafting ratios (Fig. 1a, where m and n are 
the equivalent of CD and that of acrylamide, respectively) forms 
a multivalent, fluorescence-enhanced glycodot, which can be 
subsequently self-assembled with a biocompatible 2D material 
(manganese dioxide – MnO2), producing the stimulus-
responsive, fluorogenic 2D probe (Fig. 1b) capable of target-
specific imaging of liver cancer and triple-negative breast cancer 
cells (Fig. 1c). 
 
Fig. 2 Concentration-dependent fluorescence enhancement of (a) Man-probe (1 
μM) with increasing poly-CD100 (0-90 μg mL-1; interval: 15 μg mL-1) and (d) Gal-
probe (1 μM) with increasing poly-CD6 (0-90 μg mL-1; interval: 15 μg mL-1). 
Concentration-dependent fluorescence quenching of (b) Man-dot (Man-
probe/poly-CD100 = 1 μM/80 μg mL-1) and (e) Gal-dot (Gal-probe/poly-CD6 = 1 
μM/80 μg mL-1) with increasing 2D MnO2 (0-5 μg mL-1; interval: 1 μg mL-1). 
Concentration-dependent fluorescence recovery of (c) 2D Man-probe (Man-
probe/poly-CD100/2D MnO2 = 1 μM/80 μg mL-1/5 μg mL-1) with increasing GSH and 
concanavalin A (Con A, a mannose selective lectin) and (f) 2D Gal-probe (Gal-
probe/poly-CD6/2D MnO2 = 1 μM/80 μg mL-1/5 μg mL-1) with increasing GSH and 
peanut agglutinin (PNA, a galactose selective lectin). The fluorescence spectra for 
glycoprobes and glycodots were obtained in phosphate buffered saline (PBS, 0.01 
M, pH 7.4). The fluorescence spectra for 2D probes were obtained in Tris-HCl (0.01 
M, pH 7.4). Excitation wavelength: 450 nm; slit widths ex = 5 nm and em = 5 nm. 
Cyclodextrins (CDs) have been widely used as a macrocyclic 
host molecule by the supramolecular inclusion of hydrophobic 
guest compounds in aqueous solution. The supramolecular 
“host-guest” chemistry of CDs plays an important role in 
photochemistry, analytical science, materials science and 
chemical biology. They have also been used extensively for 
enhancing the drug-delivering efficacy in vivo.8,9 With the rapid 
progress in the discovery of advanced new materials, a myriad 
of 2D materials have been synthesized and employed for 
biosensing and bioimaging.10 Of the 2D materials developed, 
thin-layer MnO2 has proven to be rapidly degradable in the 
presence of reducing agents11 such as the physiologically 
important glutathione (GSH) that exists at higher levels in 
cancer cells.12,13 However, efforts to incorporate the 
biocompatible poly-CD with 2D MnO2 producing functional 
material architectures for biomedical applications remain rare. 
To the best of our knowledge, we describe the first 
supramolecular ensemble formed between functionalized poly-
CDs and 2D MnO2 for targeted, biothiol-responsive 
fluorescence imaging. We began with the design and synthesis 
of a naphthalimide glycoprobe (Fig. 1a and Scheme S1). In 
previous studies, we have shown that the introduction of 
carbohydrate targeting agents to naphthalimide based probes 
significantly enhanced their cell-targeting ability and imaging of 
intracellular species14 with a lowered cytotoxicity. We 
synthesized two such glyco-naphthalimide probes with 
galactose and mannose as the targeting ligand for the 
asialoglycoprotein receptor (ASGPr) and mannose receptor (MR) 
that exist on the surface of different cancer cells, respectively. 
An additional adamantane group was introduced to the probes 
for host-guest assembly with CDs,15,16 producing the Man-
probe and Gal-probe (Fig. 1a). The CD monomer (6-acrylamido-
β-CD) was synthesized according to the literature,17 and a 
subsequent radical binary copolymerization between 
acrylamide and the CD-monomer with different loading 
concentrations afforded the poly-CDs with different CD-grafting 
ratios (poly-CD6, poly-CD100 and poly-CD300, where the numbers 
refer to the equivalent of acrylamide in the co-polymer). 
With the compounds and polymers ready, the self-assembly 
was carried out in a phosphate buffered saline (PBS, 0.01 M, pH 
7.4) as solvent. We determined that the fluorescence of the two 
glycoprobes enhanced gradually with added poly-CDs (Fig. 2a 
and Fig. 2d for Man-probe with poly-CD100 and Gal-probe with 
poly-CD6, respectively; for fluorescence spectra of the 
glycoprobes with all the poly-CDs, see Fig. S1a), suggesting that 
the host-guest insertion of adamantane to the CD cavities might 
enhance the hydrophobic environment and thus enhance the 
fluorescence emission.18,19 We then observed that the 
enhanced fluorescence intensity of the probes was proportional 
to the CD density of the polymers (poly-CD6> poly-CD100> poly-
CD300) (Fig. S1b). This suggests that the polymers with a higher 
CD density can host more guest molecules to better enhance 
the overall fluorescence emission. To corroborate that the 
fluorescence enhancement was the result of host-guest 
interactions, we used 1-bromonaphthalene as a competing 
molecule. The results indicated that the presence of 1-
bromonaphthalene decreased the fluorescence of the 
glycoprobe/poly-CD ensembles (glycodots), suggesting the 
interruption of the adamantane-CD binding (Fig. S2). 
Having developed the glycodots, we set out to further 
construct the 2D probe. The glycodots were mixed with an 
aqueous dispersion of 2D MnO2 (with a size distribution in the 
nanometer range – Fig. S3) produced using an established 
method.20 Then, the assembly was measured by fluorescence 
spectroscopy. We observed a concentration-dependent 
fluorescence decrease of the glycodots with 2D MnO2 (Fig. 2b 
and Fig. 2e for a Man-dot and a Gal-dot, respectively), which is 
in agreement with the fluorescence quenching property of the 
2D material for surface-bound fluorophores.21,22 The quenching 
plateau was reached with 5 μg mL-1 of the 2D material. The 2D 
probes were shown to be thermally stable over a temperature 
range of 0-200 °C as determined by thermogravimetric analysis. 
(Fig. S4). 
Next, we tested the stability of the 2D probes with both 
lectins (proteins that selectively recognize carbohydrates) and 
GSH. Interestingly, whereas the presence of selective lectins 
(concanavalin A and peanut agglutinin for mannose- and 
galactose-based glycodots, respectively) caused minimal 
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fluorescence recovery, the addition of GSH completely restored 
the fluorescence of the glycodots (Fig. 2c and Fig. 2f for 2D Man-
probe and 2D Gal-probe, respectively; for original fluorescence 
spectra, see Fig. S5). This implies that the poly-CD probes are 
stably immobilized on the surface of 2D MnO2, whereas the 
degradation of the substrate material by GSH23 released the 
fluorescent polymers, thus producing a stimulus-responsive, 
fluorogenic 2D probe. The stability over carbohydrate receptors 
is meaningful since we envision that the glycodots on the 
material surface would remain integrated upon receptor 
endocytosis at the cellular level but become activated only 
when a target intracellular biomarker for material disruption 
exists, thereby improving the imaging accuracy. 
With these promising solution-based results in hand, we 
evaluated the imaging ability of the 2D probes. We first used the 
glycodots consisting of different polymer backbones and 
glycoprobes to optimize the imaging condition. Two cancer cell 
lines, i.e. a triple-negative breast cancer cell line (MDA-MB-231) 
that overly expresses MR24 and a liver cancer cell line (Hep-G2) 
that overly expresses ASGPr25 were used. We determined that 
the density in CD fraction of the poly-CDs had a significant 
impact on the imaging efficiency. The poly-CD100 and poly-CD6 
scaffold produced the highest imaging brightness for MDA-MB-
231 and Hep-G2 cells, respectively, among other control poly-
CDs (Fig. S6). This suggests the sharp difference in preferred 
multivalent glycostructures of ASGPr and MR probably because 
of the different membrane-bound architectures of the 
receptors.26-28  
 
Fig. 3 Fluorescence (a) imaging and (b) quantification (***P< 0.001 with respect 
to the group of glycoprobe alone for target cells) of MDA-MB-231 (human triple-
negative breast cancer), Hep-G2 (human liver cancer) and A549 (human lung 
cancer) cells with glycoprobe alone (8 μM) or glycodots (glycoprobe/poly-CD = 8 
μM/640 μg mL-1). Scale bars = 100 μm. The excitation and emission channels used 
are 460-490 nm and 530-590 nm, respectively. The cell nuclei were stained by 
Hoechst 33342. 
To corroborate the receptor-targeting ability of the probes, a 
competition assay was carried out. The result indicated that the 
presence of increasing free D-mannose and D-galactose 
gradually suppressed the fluorescence of poly-CD100 and poly-
CD6 probe produced in MDA-MB-231 and Hep-G2 cells, 
respectively (Fig. S7). In addition, the use of a control cell line 
(human lung cancer – A549) with minimal ASGPr and MR 
expression as determined by real-time quantitative polymerase 
chain reaction (Fig. S8) also confirmed the excellent targeting 
ability of the multivalent glycodots for the MR-expressing and 
ASGPr-expressing cells (Fig. 3). We also noted that the 
selectivity of the glyco-dots for the target cancer cell was much 
higher than that of the glycoprobes alone (Fig. 3), which could 
be ascribed to the multivalency of the glycodots to enhance the 
binding avidity with the selective receptors on the cell surface. 
 
Fig. 4 Fluorescence (a) imaging and (b) quantification (***P< 0.001 with respect 
to the group of untreated cells) of MDA-MB-231 (human triple-negative breast 
cancer) and Hep-G2 (human liver cancer) cells with or without treatment of NEM 
or exo-GSH upon incubation with 2D probes (glycoprobe/poly-CD/2D MnO2 = 4 
μM/320 μg mL-1/12 μg mL-1). Scale bars = 100 μm. The excitation and emission 
channels used are 460-490 nm and 530-590 nm, respectively. The cell nuclei were 
stained by Hoechst 33342. 
Encouraged by these results, we used the thin-layer MnO2 
based 2D probes for GSH-responsive imaging of the target 
cancer cells. Owing to the presence of a high level of 
endogenous GSH in cancer cells,29-31 the cells were pre-treated 
with NEM (a GSH quencher)32 followed by incubation of 
exogenous GSH to examine the sensitivity of the probes. We 
observed that the fluorescence of the 2D probes produced in 
untreated MDA-MB-231 was almost completely supressed in 
the cells pre-treated with NEM (N-ethylmaleimide) (Fig. 4). 
However, the subsequent addition of exogenous GSH further 
enhanced the fluorescence. These results indicate that 1) the 
2D probe is GSH-responsive probably through the intracellular 
degradation of 2D MnO2 by GSH found in the cells, and that 2) 
the 2D probe does not produce the imaging signal without 
intracellular GSH, suggesting good stability of the 
supramolecular architecture. The second point is particularly 
important for imaging probes since false-positive signals 
produced by the non-specific interaction within complex 
cellular environments could be minimized. 
To conclude, we have developed a 2D probe for the targeted, 
fluorogenic imaging of cancer cells through both host-guest 
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interactions and self-assembly between fluorescent polymers 
and 2D materials. The simplicity in material construction yet 
effectiveness of the probes for stimulus-responsive fluorogenic 
imaging makes it possible to extend these systems for an even 
wider diversity of supramolecular, biocompatible imaging 
probes for functional bioimaging. 
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